Napoleone Ferrara, MD, Distinguished Professor of Pathology and Distinguished Adjunct Professor of Ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the António Champalimaud Vision Award in Lisbon, Portugal.
Autism spectrum disorder (ASD) is now estimated to impact one in every 68 children born in the United States. A new 5-year, $5.1 million grant from the National Institute of Mental Health (NIMH) seeks expand a program developed by researchers at University of California, San Diego School of Medicine to reduce the mean age of ASD diagnosis in multiple cities across the U.S.
Computer scientists at the University of California, San Diego have successfully funded on Kickstarter a new and improved version of CodeSpells, a first-person player game they developed that teaches players how to code.
The work took nearly four years to complete and it opens a fundamentally new direction in photonics – with far-reaching potential consequences for the control of photons in optical fiber channels.
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
Meanwhile, health care is increasingly moving toward the use of biometric devices – gadgets embedded with wireless sensors – to unobtrusively monitor patients’ health data in real time, from blood pressure and insulin levels to number of steps walked per day.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
